acetylcysteine has been researched along with Uremia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Baum, E; Breborowicz, A; Misian, M | 1 |
| Breborowicz, A; Mackowiak, B; Sosinska-Zawierucha, P | 1 |
| Dallin, FT; França, KC; Fujihara, CK; Nakao, LS; Nascimento, AJ; Pecoits-Filho, R; Rodrigues, SD | 1 |
| Azevedo, M; Barreto, FC; Bonan, NB; Kotanko, P; Kuntsevich, V; Moreno-Amaral, AN; Nakao, LS; Pecoits-Filho, R; Ronco, C; Steiner, TM; Thijssen, S; Virzì, GM | 1 |
| Li, Y; Xu, G; Yang, P | 1 |
| Descamps-Latscha, B; Drüeke, T; Gausson, V; Nguyen, AT; Santangelo, F; Touam, M; Witko-Sarsat, V | 1 |
| Descamps-Latscha, B; Drüeke, TB; Ivanovski, O; Lacour, B; Massy, ZA; Nguyen-Khoa, T; Phan, O; Ruellan, N; Szumilak, D | 1 |
| Akcar, N; Sahin, G; Yalcin, AU | 1 |
| Capasso, R; De Santo, NG; Ingrosso, D; Lombardi, C; Luciano, MG; Perna, AF; Pulzella, P; Satta, E | 1 |
| Burigo, M; Constantino, L; Dal-Pizzol, F; Di-Pietro, PB; Dias, ML; Machado, RA; Scaini, G; Streck, EL | 1 |
| Gejyo, F | 1 |
| Atoynatan, T; Bartfeld, H | 1 |
1 trial(s) available for acetylcysteine and Uremia
| Article | Year |
|---|---|
Effect of N-acetylcysteine on endothelial dysfunction in dialysis patients.
Topics: Acetylcysteine; Adult; Antioxidants; Brachial Artery; Cardiovascular Diseases; Endothelium, Vascular; Female; Hemorheology; Humans; Male; Middle Aged; Nitric Oxide; Nitroglycerin; Oxidative Stress; Renal Dialysis; Ultrasonography; Uremia; Vasodilation | 2007 |
11 other study(ies) available for acetylcysteine and Uremia
| Article | Year |
|---|---|
N-acetylcysteine modulates effect of the iron isomaltoside on peritoneal mesothelial cells.
Topics: Acetylcysteine; Adult; Cells, Cultured; Cytokines; Disaccharides; Epithelial Cells; Ferric Compounds; Fibrinolysis; Humans; Inflammation Mediators; Infusions, Intravenous; Male; Middle Aged; Oxidative Stress; Peritoneal Dialysis; Peritoneum; Phenotype; Treatment Outcome; Uremia | 2020 |
N-Acetylcysteine and Sulodexide Reduce the Prothrombotic Effect of Uremic Serum on the Venous Endothelial Cells.
Topics: Acetylcysteine; Anticoagulants; Blood Specimen Collection; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Female; Free Radical Scavengers; Glycosaminoglycans; Humans; Kidney Failure, Chronic; Male; Thrombosis; Uremia | 2019 |
N-acetylcysteine as a potential strategy to attenuate the oxidative stress induced by uremic serum in the vascular system.
Topics: Acetylcysteine; Adult; Aged; Animals; Biomarkers; Blood Vessels; Cells, Cultured; Female; Free Radical Scavengers; Glutathione; Humans; Male; Middle Aged; Myocytes, Smooth Muscle; Nephrectomy; Oxidative Stress; Rabbits; Rats; Rats, Wistar; Reactive Oxygen Species; Renal Insufficiency, Chronic; Uremia | 2015 |
Uremic Toxicity-Induced Eryptosis and Monocyte Modulation: The Erythrophagocytosis as a Novel Pathway to Renal Anemia.
Topics: Acetylcysteine; Adolescent; Adult; Aged; Aged, 80 and over; Anemia; Case-Control Studies; Coculture Techniques; Eryptosis; Erythrocytes; Female; Free Radical Scavengers; Gene Expression Regulation; GPI-Linked Proteins; Humans; Immune Sera; Lipopolysaccharide Receptors; Male; Middle Aged; Monocytes; Phagocytosis; Primary Cell Culture; Reactive Oxygen Species; Receptors, IgG; Renal Dialysis; Renal Insufficiency, Chronic; Uremia | 2016 |
Antioxidant therapy improves non-thyroidal illness syndrome in uremic rats.
Topics: Acetylcysteine; Animals; Antioxidants; Euthyroid Sick Syndromes; Female; Free Radical Scavengers; Male; Pyrrolidines; Random Allocation; Rats; Rats, Sprague-Dawley; Thiocarbamates; Uremia | 2016 |
AOPP-induced activation of human neutrophil and monocyte oxidative metabolism: a potential target for N-acetylcysteine treatment in dialysis patients.
Topics: Acetylcysteine; Blood Proteins; Dose-Response Relationship, Drug; Humans; Monocytes; NADP; Neutrophils; Oxidation-Reduction; Oxygen; Peroxidase; Platelet Activating Factor; Serum Albumin; Uremia | 2003 |
The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Topics: Acetylcysteine; Animals; Antioxidants; Aorta; Apolipoproteins E; Arteriosclerosis; Body Weight; Collagen; Female; Mice; Mice, Knockout; Tyrosine; Uremia | 2005 |
Is homocysteine toxic in uremia?
Topics: Acetylcysteine; Antitoxins; Cardiovascular Diseases; Folic Acid; Homocysteine; Humans; Hyperhomocysteinemia; Kidney Failure, Chronic; Myocardial Infarction; Recurrence; Reference Values; Renal Dialysis; Retrospective Studies; Risk Factors; Uremia | 2008 |
Inhibition of brain creatine kinase activity after renal ischemia is attenuated by N-acetylcysteine and deferoxamine administration.
Topics: Acetylcysteine; Animals; Antioxidants; Brain; Brain Diseases, Metabolic; Creatine Kinase; Deferoxamine; Down-Regulation; Ischemia; Kidney Diseases; Male; Nerve Degeneration; Oxidative Stress; Rats; Rats, Wistar; Subcellular Fractions; Time Factors; Treatment Outcome; Uremia | 2008 |
[Studies on uremic toxins--biochemical analysis of uremic serum (author's transl)].
Topics: Acetylcysteine; Aminoisobutyric Acids; beta 2-Microglobulin; Dipeptides; Humans; Toxins, Biological; Uremia | 1978 |
N-acetylcysteine inactivates migration inhibitory factor and delayed hypersensitivity reactions.
Topics: Acetylcysteine; Animals; Cell Migration Inhibition; Cell Movement; Culture Techniques; Cysteine; Guinea Pigs; Hypersensitivity, Delayed; Lymphocyte Activation; Macrophages; Pulmonary Alveoli; Uremia | 1971 |